P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Total Receivables Peer Comparison

Comparables:
068270
302440
H
145020
N
007390
196170

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Total Receivables
â‚©53.9B
CAGR 3-Years
23%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Total Receivables
â‚©975.7B
CAGR 3-Years
-10%
CAGR 5-Years
3%
CAGR 10-Years
8%
SK Bioscience Co Ltd
KRX:302440
Total Receivables
â‚©22.3B
CAGR 3-Years
-25%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Total Receivables
â‚©43.1B
CAGR 3-Years
11%
CAGR 5-Years
0%
CAGR 10-Years
N/A
N
NatureCell Co Ltd
KOSDAQ:007390
Total Receivables
â‚©10.8B
CAGR 3-Years
36%
CAGR 5-Years
19%
CAGR 10-Years
11%
Alteogen Inc
KOSDAQ:196170
Total Receivables
â‚©11.2B
CAGR 3-Years
35%
CAGR 5-Years
17%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Total Receivables?
Total Receivables
53.9B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Total Receivables amounts to 53.9B KRW.

What is PharmaResearch Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
21%

Over the last year, the Total Receivables growth was 54%. The average annual Total Receivables growth rates for PharmaResearch Co Ltd have been 23% over the past three years , 21% over the past five years .

Back to Top